e-learning
resources
Virtual 2021
05.09.2021
Biology of lung cancer: preclinical and translational research
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Identifying a tissue specific microRNA molecular signature in lung cancer
A. Tent (Cluj-Napoca, Romania), I. Berindan-Neagoe (Cluj-Napoca, Romania), I. Simon (Cluj-Napoca, Romania), M. Simon (Cluj-Napoca, Romania)
Source:
Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Session:
Biology of lung cancer: preclinical and translational research
Session type:
E-poster
Number:
1131
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Tent (Cluj-Napoca, Romania), I. Berindan-Neagoe (Cluj-Napoca, Romania), I. Simon (Cluj-Napoca, Romania), M. Simon (Cluj-Napoca, Romania). Identifying a tissue specific microRNA molecular signature in lung cancer. 1131
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Anaesthesia, sedation and tolerance (flexible and rigid bronchoscopy)
Related content which might interest you:
Gene expression profiling reveal novel biomarkers in non-small cell lung cancer
Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases
Year: 2010
Non-coding RNA as functional player and molecular marker in lung cancer
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011
Where next for lung cancer gene expression profiling?
Source: Eur Respir J 2007; 30: 5-6
Year: 2007
Multi-omic molecular profiling of lung cancer in COPD
Source: Eur Respir J, 52 (1) 1702665; 10.1183/13993003.02665-2017
Year: 2018
Circulating biomarkers and tumour molecular profiling in patients with non-small cell lung cancer
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015
Differential expression analysis of lncRNA in different types of lung cancer
Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases
Year: 2021
Expression profiling in hypoxic non-small cell lung cancer explants reveals a four-gene hypoxia signature
Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics
Year: 2011
Lung cancer biomarkers based on miRNA
Source: Virtual Congress 2021 – Biology of lung cancer: preclinical and translational research
Year: 2021
Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes
Source: ERS Lung Science Conference 2017
Year: 2017
Combined genome-wide transcriptomic and epigenetic profiling across disease stages identifies novel regulators of COPD in human lung fibroblasts
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020
Proteomic analysis of human small cell lung cancer tissues
Source: Annual Congress 2009 - Lung cancer biology
Year: 2009
DNA methylation profiling of non-small cell lung cancer reveals an immune signature in COPD patients
Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome)
Year: 2013
Pathology and molecular biology of lung cancer
Source: Annual Congress 2006 - PG19 - Thoracic oncology: diagnostic assessment of lung cancer
Year: 2006
Association between polymorphisms in microRNA target sites using CLASH data and survival of early-stage non-small cell lung cancer
Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells
Year: 2017
Causal RNA signatures in lung adenocarcinoma
Source: Virtual Congress 2020 – Biological mechanisms of lung cancer
Year: 2020
Evolution of microRNA expression during human bronchial squamous carcinogenesis
Source: Eur Respir J 2009; 33: 352-359
Year: 2009
LSC Abstract – Transcriptomic profiling of macrophages isolated from human non-small cell lung carcinoma (NSCLC) reveals novel macrophage subsets with distinct tumour response features
Source: International Congress 2016 – Lung cancer immunology: latest research
Year: 2016
Abnormal expression of let-7a miRNA in blood of lung cancer patient
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010
Identification of reference genes in lung cancer from RNA-seq data
Source: International Congress 2017 – Lung cancer - basic science: the latest results from the bench
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept